4//SEC Filing
Jerman Michael Allen 4
Accession 0001493152-24-034373
CIK 0001971532other
Filed
Aug 28, 8:00 PM ET
Accepted
Aug 29, 4:05 PM ET
Size
5.8 KB
Accession
0001493152-24-034373
Insider Transaction Report
Form 4
Jerman Michael Allen
Director
Transactions
- Award
Incentive Stock Options (right to buy)
2024-08-27+25,000→ 25,000 totalExercise: $5.02Exp: 2034-08-27→ Common Stock (25,000 underlying)
Footnotes (2)
- [F1]The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on August 26, 2024.
- [F2]The stock options were issued to the Reporting Person on August 26, 2024, pursuant to a grant under the Issuer's 2023 Omnibus Incentive Plan, as amended and restated (the "Plan"). Fifty percent of the stock options vested immediately upon issuance and the remaining fifty percent of the stock options are to vest on February 26, 2025.
Documents
Issuer
Telomir Pharmaceuticals, Inc.
CIK 0001971532
Entity typeother
Related Parties
1- filerCIK 0001979732
Filing Metadata
- Form type
- 4
- Filed
- Aug 28, 8:00 PM ET
- Accepted
- Aug 29, 4:05 PM ET
- Size
- 5.8 KB